• Banner

  • Reduced price
Therapeutic Targets for Diabetic Retinopathy

Therapeutic Targets for Diabetic Retinopathy

A Translational Approach

9780323930642
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
372,91 zł
316,97 zł Save 55,94 zł Tax included
Lowest price within 30 days before promotion: 316,97 zł
Quantity
Available in 4-6 weeks

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Description
Therapeutic Targets For Diabetic Retinopathy:: A Translational Approach offers a consolidated view of this complex disorder by summarizing the latest evidence-based studies and translating their findings into practical, actionable knowledge. This concise resource covers the fundamentals of diabetic retinopathy and diabetic macular edema with an emphasis on basic science and therapeutic targets on the horizon. Ophthalmologists, optometrists, and researchers will find the translational approach to this common eye disorder to be useful in both research and clinical practice settings.
Product Details
Elsevier
93890
9780323930642
9780323930642

Data sheet

Rok wydania
2023
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
322
Wymiary (mm)
191 x 235
Waga (g)
700
  • 1. Introduction of diabetic retinopathy and principles of treatment
    2. Diabetes-induced metabolic disorders of diabetic retinopathy
    3. Diabetic retinopathy, a neurovascular unit disease
    4. The pathogenic role of apoptosis in the development of diabetic retinopathy
    5. Diabetic retinopathy, a disease with low-grade inflammation
    6. Neurodegeneration and microangiopathy in diabetic retina and choroid
    7. Proliferative diabetic retinopathy, a disease of pathologic angiogenesis and vasculogenesis
    8. Pathogenesis of diabetic macular edema
    9. Treatments for diabetic retinopathy and diabetic macular edema in pipeline
    10. Future perspectives for diabetic retinopathy management

Comments (0)